Skip to main content
. Author manuscript; available in PMC: 2011 Feb 15.
Published in final edited form as: Spine (Phila Pa 1976). 2010 Feb 15;35(4):439–446. doi: 10.1097/BRS.0b013e3181bdafb9

Table 3. Subgroup results from common adjusting covariates* as-treated outcome analysis by number of levels with moderate or severe stenosis for the randomized and observational SPS cohorts combined.

Analysis results from adjusted as-treated outcome analysis by number of levels with moderate or severe stenosis for the randomized and observational cohort for patients with isolated spinal stenosis.

SPS cohort 3-Months 1-Year 2-Year

Outcomes Stenosis Level Surgical Non-operative Treatment Effect** (95% CI) Surgical Non-operative Treatment Effect** (95% CI) Surgical Non-operative Treatment Effect** (95% CI)

SF-36 Bodily Pain (BP) (0-100(SE) One 31 (2) 13.2 (2.1) 17.8 (12.8, 22.9) 29.6 (2.2) 16.8 (2.4) 12.8 (7, 18.6) 28.6 (2.1) 17.3 (2.5) 11.2 (5.2, 17.3)
Two 27.9 (1.9) 12 (2) 15.9 (11, 20.8) 27.6 (2.1) 11.5 (2.4) 16.1 (10.3, 21.9) 27.9 (2.1) 12.8 (2.5) 15.1 (9, 21.1)
Three+ 30.5 (2.5) 15 (2.9) 15.5 (8.8, 22.3) 33.8 (2.5) 16.4 (3.2) 17.4 (9.8, 25.1) 28.7 (2.5) 13.9 (3.4) 14.7 (6.9, 22.6)
pvalue 0.49 0.69 0.81 0.16 0.23 0.58 0.96 0.43 0.63

SF-36 Physical Function (PF) (0-100) (SE) One 25.3 (1.9) 11.7 (2) 13.7 (9, 18.3) 26.4 (2.1) 12.9 (2.2) 13.5 (8.1, 18.9) 23 (2) 13.7 (2.4) 9.3 (3.7, 15)
Two 22.7 (1.8) 8.1 (1.9) 14.6 (10, 19.1) 23.2 (2) 9.3 (2.2) 13.9 (8.6, 19.3) 21.5 (2) 10.5 (2.4) 11 (5.4, 16.6)
Three+ 26.8 (2.4) 10.5 (2.7) 16.4 (10.1, 22.6) 30.6 (2.4) 9.4 (3.1) 21.3 (14.1, 28.4) 25.2 (2.4) 10.4 (3.2) 14.7 (7.4, 22.1)
pvalue 0.34 0.42 0.79 0.057 0.47 0.18 0.48 0.59 0.51

Mental Component Summary (MCS) (0-100) (SE) One 3.9 (0.8) 2.2 (0.9) 1.7 (-0.5, 3.8) 2.8 (0.9) 2.6 (1) 0.2 (-2.2, 2.7) 2.8 (0.9) 1.5 (1) 1.3 (-1.3, 3.9)
Two 4 (0.8) 1.5 (0.8) 2.5 (0.4, 4.6) 3.6 (0.9) 1.2 (1) 2.4 (-0.1, 4.8) 4 (0.9) 1.7 (1) 2.2 (-0.3, 4.8)
Three+ 4.2 (1) 2.4 (1.2) 1.8 (-1.1, 4.6) 5.1 (1) 3.5 (1.3) 1.6 (-1.6, 4.8) 4.7 (1) -0.4 (1.4) 5.1 (1.8, 8.4)
pvalue 0.98 0.79 0.84 0.27 0.34 0.46 0.35 0.43 0.19

Oswestry Disability Index (ODI) (0-100) (SE) One -20.6 (1.6) -8.9 (1.6) -11.7 (-15.5, -7.9) -19.9 (1.7) -10.6 (1.8) -9.3 (-13.7, -4.9) -19.8 (1.6) -10.4 (1.9) -9.4 (-14, -4.8)
Two -21.3 (1.5) -5.1 (1.6) -16.2 (-19.9, -12.5) -20.6 (1.6) -7.4 (1.8) -13.2 (-17.6, -8.8) -20.2 (1.6) -9.4 (1.9) -10.7 (-15.3, -6.2)
Three+ -22.4 (1.9) -9.6 (2.2) -12.8 (-17.9, -7.7) -24.4 (2) -8.4 (2.5) -16 (-21.8, -10.2) -21.9 (1.9) -6.3 (2.6) -15.7 (-21.6, -9.7)
pvalue 0.78 0.12 0.21 0.19 0.46 0.17 0.68 0.45 0.25

Stenosis Frequency Index (0-24) (SE)§ One -7.7 (0.7) -3.3 (0.6) -4.4 (-6, -2.8) -7.3 (0.6) -3.8 (0.6) -3.4 (-5, -1.8) -6.9 (0.6) -4.4 (0.7) -2.6 (-4.3, -0.9)
Two -7.5 (0.7) -2 (0.6) -5.5 (-7.2, -3.8) -7 (0.6) -2.9 (0.6) -4.1 (-5.7, -2.5) -7.3 (0.6) -3.9 (0.7) -3.3 (-5.1, -1.6)
Three+ -8.6 (0.8) -3.5 (0.8) -5 (-7.2, -2.9) -8.3 (0.7) -4.1 (0.9) -4.2 (-6.3, -2.1) -7.4 (0.7) -2.8 (0.9) -4.6 (-6.8, -2.4)
pvalue 0.60 0.13 0.65 0.30 0.43 0.79 0.85 0.43 0.35

Stenosis Bothersomeness Index (0-24) (SE)§ One -8.4 (0.7) -3.4 (0.6) -4.9 (-6.6, -3.3) -8.2 (0.6) -4 (0.6) -4.2 (-5.8, -2.6) -7.4 (0.6) -4.5 (0.7) -2.8 (-4.5,-1.1)
Two -8.5 (0.7) -2.2 (0.6) -6.3 (-8, -4.5) -7.7 (0.6) -3.7 (0.7) -4.1 (-5.7, -2.4) -8.1 (0.6) -4.3 (0.7) -3.7 (-5.5, -2)
Three+ -8.9 (0.8) -3.2 (0.8) -5.7 (-7.8, -3.5) -9 (0.7) -3.9 (0.9) -5.2 (-7.3, -3) -8 (0.7) -4.1 (0.9) -3.9 (-6.1, -1.7)
pvalue 0.89 0.27 0.53 0.33 0.95 0.68 0.66 0.92 0.66

Low Back Pain Bothersomeness (0-6) (SE) One -1.8 (0.2) -0.8 (0.2) -1 (-1.5, -0.5) -2 (0.2) -1 (0.2) -1 (-1.5, -0.5) -2.1 (0.2) -1.3 (0.2) -0.8 (-1.3, -0.3)
Two -2.2 (0.2) -0.8 (0.2) -1.4 (-1.9, -0.9) -1.9 (0.2) -1.1 (0.2) -0.8 (-1.3, -0.3) -1.9 (0.2) -1.1 (0.2) -0.8 (-1.3, -0.3)
Three+ -2 (0.2) -1 (0.2) -1 (-1.6, -0.4) -2.2 (0.2) -1 (0.3) -1.2 (-1.8, -0.6) -2.1 (0.2) -0.8 (0.3) -1.3 (-1.9, -0.7)
pvalue 0.42 0.64 0.43 0.39 0.94 0.58 0.75 0.28 0.35

Very/somewhat satisfied with symptoms (%) One 62.1 24.7 37.4 (26.1, 48.7) 67.3 28.9 38.4 (25.4, 51.4) 63.8 44.7 19.1 (4.3, 33.9)
Two 63.2 21.7 41.5 (30.8, 52.2) 62.3 29.7 32.6 (19.3, 45.8) 71.5 22 49.5 (37, 62)
Three+ 56.1 24.9 31.2 (16.3, 46.1) 75.3 32.1 43.2 (26.7, 59.7) 69 21.2 47.8 (32, 63.6)
pvalue 0.59 0.83 0.57 0.19 0.93 0.61 0.48 0.01 0.005

Self-rated progress major improvement (%) One 72.4 23.9 48.4 (38, 58.9) 65.9 27.6 38.3 (25.6, 51) 62.3 36.2 26.1 (12.1, 40.2)
Two 70.4 17.6 52.8 (43.2, 62.4) 66.1 24.8 41.3 (29, 53.7) 64.7 25.2 39.5 (26.5, 52.5)
Three+ 71.6 17.3 54.2 (41.4, 67.1) 74.6 26.4 48.2 (32.7, 63.8) 59.4 24.5 34.9 (18.2, 51.6)
pvalue 0.95 0.43 0.70 0.39 0.92 0.63 0.77 0.30 0.42
*

Adjusted for age, gender, stomach comorbidity, SLR or femoral tension sign, smoking status, joint comorbidity, patient self assessed health trend, income, compensation, bmi, baseline score (for SF-36 and ODI), and center.

The SF-36 scores range from 0 to 100, with higher score indicating less severe symptoms.

The Oswestry Disability Index ranges from 1 to 100, with lower scores indicating less severe symptoms.

§

The Stenosis Bothersomeness Index and the Stenosis Frequency Index range from 0 to 24, with lower scores indicating less severe symptoms.

The Low Back Pain Bothersomness Scale ranges from 0 to 6, with lower scores indicating less severe symptoms

**

Treatment effect is the difference between the surgical and non-operative mean change from baseline. Analysis is done using a mixed model with a random subject intercept term. Treatment is a time-varying covariate where a patients' experience prior to surgery is attributed to the non-operative arm and time is measured from enrollment and his/her post-surgery outcomes are attributed to the surgical arm and time is measured from time of surgery.